The potential therapeutic use of stem cells in cartilage repair

Current Stem Cell Research and Therapy

Volumn 7, Issue 2, 2012, Pages 149-156

  Perera, Jonathan R ^a   Jaiswal, Parag K ^a   Khan, Wasim S ^b  

^a ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cartilage repair; Cell surface markers; Chondrogenesis; Mesenchymal stem cells; Osteoarthritis; Tissue engineering

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA SMOOTH MUSCLE ACTIN; ALPHA1 INTEGRIN; BETA1 INTEGRIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; CD11B ANTIGEN; CD133 ANTIGEN; CD14 ANTIGEN; CD146 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD71 ANTIGEN; CELL MARKER; CHEMOKINE RECEPTOR CXCR4; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DECAY ACCELERATING FACTOR; ENDOGLIN; GROWTH DIFFERENTIATION FACTOR; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE; CARTILAGE CELL; CARTILAGE REPAIR; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; EMBRYO CELL; EMBRYOLOGICAL STEM CELL; EMBRYOLOGY; HUMAN; MESENCHYMAL STEM CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; STEM CELL; TISSUE ENGINEERING; TISSUE REGENERATION;

CARTILAGE, ARTICULAR; CHONDROCYTES; HUMANS; OSTEOARTHRITIS; REGENERATIVE MEDICINE; STEM CELLS; TISSUE ENGINEERING;

EID: 84857694582     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488812799219054     Document Type: Article

References (96)

1. Becker AJ, McCulloch EA, Till JE. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 1963; 197: 452-4.
2. Schofield R. The relationship between the spleen colony forming cell and the haematopoietic stem cell. Blood Cells 1978; 4: 7-25.
3. Evans CH, Ghivizzani SC, Robbins PD. Orthopaedic gene therapy in 2008. Mol Ther 2009; 17 (2): 231-44.
4. Poole AR. Imbalance of anabolism and catabolism of cartilage matrix components in osteoarthritis. In: Kuettner KE, Goldberg B Eds. Osteoarthritic disorders. Rosemont: AAOS 1995: 247-60.
5. Hardingham TE. Pathophysiology of musculoskeletal disease. In Oxford Textbook of Rheumatology. Maddison PJ, Isenberg DA, Woo P, Glass DN Eds. Second edition Oxford Medical Publications 1998: 1-10.
6. Hardingham TE, Fosang AJ. Proteoglycans: many forms and many functions. FASEB J 1992; 6: 861-70.
7. Eyre DR. The collagens of articular cartilage. Semin Arthritis Rheum 1991; 21: 2-11.
8. Magne D, Julien M, Vinatier C, Merhi-Soussi F, Weiss P, Guicheux J. Cartilage formation in growth plate and arteries: from physiology to pathology. Bioessays 2005; 27: 708-16.
9. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002; 2: 389-406.
10. Newman A. Articular cartilage repair. Am J Sports Med 1998; 26: 309-24.
11. Shapiro F, Koide S, Glimcher MJ. Cell origin and differentiation in the repair of full thickness defects of articular cartilage. J Bone Joint Surg Am 1993; 5: 532-53.
12. Simon L. Osteoarthritis: a review. Clin Cornerstone 1999; 2: 26-37.
13. Buckwalter JA. Articular cartilage injuries. Clin Orthop Relat Res 2002; 402: 21-37.
14. Schulz RM, Bader A. Cartilage tissue engineering and bioreactor systems for the cultivation and stimulation of chondrocytes. Eur Biophys J 2007; 36: 539-68.
15. Risbud MV, Sittinger M. Tissue engineering: advances in in vitro cartilage generation. Trends Biotech 2002; 20: 351-6.
16. Chia SL, Sawaji Y, Burleigh A, et al. Fibroblast growth factor 2 is an intrinsic chondro-protective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum 2009; 60: 2019-27.
17. Wollheim F. Current pharmacological treatments of osteoarthritis. Drugs 1996; 52: 27-38.
18. Gao J, Yao JQ, Caplan AI. Stem Cells for tissue engineering of articular cartilage. Proc IMechE Part H: Engineering in Medicine 2007; 221: 441-450.
19. Wakitani S, Takaoka K, Hattori T, et al. Embryonic stem cells injected into the mouse knee joint form teratomas and destroy the joint. Rheumatology 2003; 42 (1): 162-65.
20. Kieffer E, Kuntz S, Viville S. An overview of pluripotent stem cell lines. Med Sci (Paris) 2010; 26 (10): 848-54.
21. Izadpanah R, Trygg C, Patel B, et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 2006; 99: 1285-597.
22. Takahashi K and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126 (4): 663-76.
23. Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R. Human embryonic stem cell lines derived from single blastomeres. Nature 2006; 444: 481-5.
24. Li L, Tian H, Yue W, Zhu F, Li S, Li W. Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo. J Cell Physiol 2010 Nov 10. [Epub ahead of print]
25. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968; 6 (2): 230-47.
26. Pittenger MF, MacKay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284 (5411): 143-7
27. Kawada H, Fujita J, Kinjo K, et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 2004; 104 (12): 3581-7.
28. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995; 18 (12): 1417-26.
29. Azizi SA, Stokes D, Augelli BJ, et al. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats - similarities to astrocyte grafts. Proc Natl Acad Sci USA 1998; 95 (7): 3908-13.
30. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000; 61 (4): 364-70.
31. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005; 52 (8): 2521-9.
32. Garcia-Castro J, Balas A, Ramirez M, et al. Mesenchymal stem cells are of recipient origin in pediatric transplantations using umbilical cord blood, peripheral blood, or bone marrow. J Pediatr Hematol Oncol 2007; 29 (6): 388-92.
33. Koch TG, Heerkens T, Thomsen PD, Betts DH. Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol 2007; 7: 26.
34. Miao Z, Jin J, Chen L, et al. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 2006; 30 (9): 681-7.
35. Tsutsumi S, Shimazu A, Miyazaki K, et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 2001; 288: 413-9.
36. Metcalk D. The unsolved enigmas of leukaemia inhibitory factor. Stem Cells 2003; 21: 5-14.
37. Huang JI, Kazmi N, Durbhakala MM, Hering TM, Yoo JU, Johnstone B. Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J Orthop Res 2005; 23 (6): 1383-9.
38. Im GI, Shin YW, Lee KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage 2005; 13 (10): 845-53.
39. Vidal MA, Robinson SO, Lopez MJ, et al. Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow. Vet Surg 2008; 37: 713-24.
40. Nejadnik H, Hui JH, Choong EP, Tai BC, Lee EH. Autologous Bone Marrow-Derived Mesenchymal Stem Cells versus Autologous Chondrocyte Implantation: An Observational Cohort Study. Am J Sports Med 2010; 38(6): 1110-6.
41. Pelttari K, Winter A, Steck E, et al. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 2006; 54: 3254-66.
42. Slavkin HC: Molecular biology of dental development: A review. In: The Biochemical Mechanism of Tooth Eruption and Root Resorption; Davidovitch Z, Ed. EbscoMed, Birmingham, AL, 1988; pp. 107-16.
43. Caplan AI. Bone Development and Repair. BioEssays 1987; 6: 171-5.
44. Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 2003; 18: 696-704.
45. Chapel A, Bertho JM, Bensidhoum M, et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiationinduced multi-organ failure syndrome. J Gene Med 2003; 5 (12): 1028-38.
46. Shake JG, Gruber PJ, Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 2002; 73 (6): 1919-25.
47. Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003; 108 (7): 863-8.
48. Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003; 48 (12): 3464-74.
49. Pittinger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004; 95: 9-20.
50. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrow derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992; 13: 69-80.
51. Barry FP, Boynton RE, Haynesworth S, Murphy JM, Zaia J. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognises an epitope on endoglin (CD105). Biochem Biophys Res Commun 1999; 265: 134-9.
52. Jones EA, Kinsey SE, English A, et al. Isolation and characterisation of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002; 46: 3349-60.
53. Raghunath J, Salacinski HJ, Sales KM, Butler PE, Seifalian M. Advancing cartilage tissue engineering: the application of stem cell technology. Curr Opin Biotech 2005; 16: 503-9.
54. Baddoo M, Hill K, Wilkinson R, et al. Characterisation of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 2003; 89: 1235-49.
55. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL. Isolation of bone marrow mesenchymal stem cells by antinerve growth factor receptor antibodies. Exp Haematol 2002; 30: 783-91.
56. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991; 78: 55-62.
57. Dennis JE, Carbillet JP, Caplan AI, Charbord P. The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs 2002; 170: 73-82.
58. Wickham MQ, Erickson GR, Gimble JM, Vail TP, Guilak F. Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop 2003; 412: 196-212.
59. Mochizuki T, Muneta T, Sakaguchi Y, et al. Higher chondrogenic potential of fibrous synovium- and adipose synovium- derived cells compared with subcutaneous fat- derived cells. Arthritis Rheum 2006; 54: 843-53.
60. Gronthos S, Graves SE, Ohta S, Simmons PJ. The STRO-1+ fraction of adult human bone marrow contains osteogenic precursors. Blood 1994; 84: 4164-73.
61. Gronthos S, Zannettino AC, Graves SE, Ohta S, Hay SJ, Simmons PJ. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 1999; 14: 47-56.
62. Dennis JE, Caplan AI. Bone marrow mesenchymal stem cells. Stem cell handbook by Stewart Sell. Humana Press; 2000.
63. Vaananen HK. Mesenchymal stem cells. Ann Med 2005; 37: 469-79.
64. Bruder SP, Ricalton NS, Boynton RE, et al. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leucocyte cell adhesion molecule and is involved in osteogenic differentiation. J Bone Miner Res 1998; 13: 655-63.
65. Khan WS, Adesida AB, Tew SR, Lowe ET, Hardingham TE. Bone Marrow Derived Mesenchymal Stem Cells Express the Pericyte Marker 3G5 in Culture and Show Enhanced Chondrogenesis in Hypoxic Conditions. J Orthop Res 2010; 28(6): 834-40.
66. Khan WS, Adesida AB, Hardingham TE. Hypoxic conditions increase hypoxia-inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthritis Res Ther 2007; 9: R55.
67. Suva D, Garavaglia G, Menetrey J, et al. Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells. J Cell Physiol 2004; 198: 110-8.
68. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001; 44: 1928-42.
69. Khan WS, Tew SR, Adesida AB, Hardingham TE. Human infrapatellar fat pad-derived stem cells express the pericyte marker 3G5 and show enhanced chondrogenesis after expansion in fibroblast growth factor-2. Arthritis Res Ther 2008; 10: R74.
70. Bruder SP, Horowitz MC, Mosca JD, Haynesworth SE. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 1997; 21: 225-35.
71. Stewart K, Walsh S, Screen J, et al. Further characterisation of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells. J Bone Miner Res 1999; 14: 1345-56.
72. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Haematol 2000; 28: 875-84.
73. Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, Bouloumie A. Improvement of postnatal neovascularisation by human adipose tissue derived stem cells. Circulation 2004; 110: 349-55.
74. Garcia-Pacheco JM, Oliver C, Kimatrai M, Blanco FJ, Olivares EG. Human decidual stromal cells express CD34 and STRO-1 and are related to bone marrow stromal precursors. Mol Hum Reprod 2001; 7: 1151-7.
75. Honczarenko M, Le Y, Swierkowski M, et al. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006; 24 (4): 1030-41.
76. Ponomaryov T, Peled A, Petit I, et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 2000; 106 (11): 1331-9.
77. Honczarenko M, Le Y, Swierkowski M, et al. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006; 24 (4): 1030-41.
78. Luyten FP, Chen P, Paralkar V, Reddi AH. Recombinant bone morphogenetic protein-4, transforming factor-beta 1, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro. Exp Cell Res 1994; 210: 224-9.
79. Sekiya I, Colter DC, Prockop DJ. BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. Biochem Biophys Res Commun 2001; 284: 411-8.
80. Kaps C, Bramlage C, Smolian H, et al. Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. Arthritis Rheum 2002; 46: 149-62.
81. Fan J, Gong Y, Ren L, Varshney RR, Cai D, Wang DA. In vitro engineered cartilage using synovium-derived mesenchymal stem cells with injectable gellan hydrogels. Acta Biomater 2010; 6 (3): 1178-85.
82. Cassiede P, Dennis JE, Ma F, Caplan AI. Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGFbeta 1 or PDGF-BB as assayed in vivo and in vitro. J Bone Miner Res 1996; 11: 1264-73.
83. Verschure PJ, Van Noorden CJ, van Marle J, van den Berg WB. Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes. Histochem J 1996; 28: 835-57.
84. Wang L, Detamore MS. Insulin-like growth factor-I improves chondrogenesis of predifferentiated human umbilical cord mesenchymal stromal cells. J Orthop Res 2009; 27 (8): 1109-15.
85. Fortier LA, Mohammed HO, Lust G, Nixon AJ. Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br 2002; 84 (2): 276-88.
86. Mishra A, Tummala P, King A, et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods 2009; 15: 431-5.
87. Akeda K, An HS, Okuma M, et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage 2006; 14: 1272-80.
88. Friedenstein AJ, Deriglasova UF, Kulagina NN, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974; 2 (2): 83-92.
89. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4 (5): 267-74.
90. Lin G, Liu G, Banie L, et al. Tissue distribution of mesenchymal stem cell marker Stro-1. Stem Cells Dev 2011; 20(10): 1747-52.
91. Gronthos S, Zannettino AC, Hay SJ, et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003; 116: 1827-35.
92. Tuli R, Tuli S, Nandi S, et al. Characterisation of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells 2003; 21: 681-93.
93. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-95.
94. Aicher WK, Bühring HJ, Hart M, Rolauffs B, Badke A, Klein G. Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells-Potential and pitfalls. Adv Drug Deliv Rev 2011; 63(4-5): 342-51.
95. Haleem AM, Singergy AA, Sabry D, et al. The Clinical Use of Human Culture-Expanded Autologous Bone Marrow Mesenchymal Stem Cells Transplanted on Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects: A Pilot Study and Preliminary Results. Cartilage 2010; 1 (4): 253-61.
96. Agar G, Blumenstein S, Bar-Ziv Y, et al. The Chondrogenic Potential of Mesenchymal Cells and Chondrocytes from Osteoarthritic Subjects: A Comparative Analysis. Cartilage 2011; 2 (1): 40-9.